Longeveron Inc. licensed stem cell technology from the University of Miami, and Joshua Hare joined the company as CSO.
1 report, 1 independent
Updated Jul 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Longeveron Inc. licensed stem cell technology from the University of Miami, and Joshua Hare joined the company as CSO.
Who's involved
What this event is mainly aboutUniversity of MiamiJoshua M Hare
Keep exploring
The entities involved
-
University of Miami
private university in Coral Gables, Florida, United States
Coverage
Newest first; wire copies grouped- GlobeNewswireLongeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease Joshua Hare Longeveron has licensed issued US Patent 12,168,028 B2, entitl